본문 바로가기

Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
PLOS ONE13(10) · 2018
피인용
Web of Science 16Scopus 19
FWCI (Scopus)
0.43
JCR IF
JCR 2017 2.766
ISSN
1932-6203

저자

  1. 김일영제1저자Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, South Korea
  2. 김준현Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, South Korea
  3. 김민정Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, South Korea
  4. 이동원Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, South Korea
  5. 황철구Medical Research Institute, Pusan National University Hospital, Busan, South Korea
  6. 한미연Medical Research Institute, Pusan National University Hospital, Busan, South Korea
  7. 이하린Medical Research Institute, Pusan National University Hospital, Busan, South Korea
  8. 송상헌Medical Research Institute, Pusan National University Hospital, Busan, South Korea
  9. 성은영Medical Research Institute, Pusan National University Hospital, Busan, South Korea
  10. 이수봉교신저자Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, South Korea

초록

Background Cardiovascular disease (CVD) is a leading cause of death in patients with chronic kidney disease (CKD). Left ventricular hypertrophy (LVH) and left ventricular diastolic dysfunction (LVDD) are known as predictors of CVD in these patients. Neutrophil gelatinase-associated lipocalin (NGAL) is a biomarker of acute kidney injury. Recently, elevated NGAL levels have been reported in patients with CVD. This study aimed to evaluate the association between plasma NGAL levels and LVH/LVDD in patients with CKD. Methods This study included 332 patients with pre-dialysis CKD (estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m(2)). Two-dimensional echocardiography was performed to measure the left ventricular mass index (LVMI). Tissue Doppler imaging was used to measure early mitral inflow velocity (E) and the peak early mitral annular velocity (E'). Diastolic function was estimated using E' and the ratio of E to E' (E/E'). The associations of echocardiographic index with clinical and laboratory variables (age, sex, diabetes, hypertension, eGFR, albumin, uric acid, calcium, phosphate, total cholesterol, hemoglobin, C-reactive protein, intact parathyroid hormone (PTH), the inferior vena cava collapse index (IVCCI) < 50%, and plasma NGAL) were investigated using univariate and multivariate analyses. Results In multivariate logistic regression analysis, plasma NGAL was an independent predictor of LVH (OR: 1.02, 95% CI: 1.01-1.02), P < 0.001). In addition, hypertension, intact PTH, and IVCCI < 50% were independent predictors of LVH. Plasma NGAL (OR: 1.02, 95% CI: 1.01-1.02, P < 0.001) was also an independent factor of LVDD. Furthermore, hypertension, intact PTH, and IVCCI < 50% were independent predictors of LVDD. Receiver operating characteristic curve analysis (area under the curve: 0.835, 95% CI: 0.792-0.879) showed the best cutoff value of plasma NGAL for identifying LVDD was >= 258 ng/ml with an associated sensitivity of 77.6% and a specificity of 87.6%. Conclusion Plasma NGAL levels were independent predictors of LVH and LVDD in patients with predialysis CKD, suggesting that plasma NGAL could be a biomarker for LVH and LVDD in these patients.

키워드

CORONARY-ARTERY-DISEASECHRONIC HEART-FAILURECARDIOVASCULAR-DISEASELEUKOCYTE ACTIVATIONNGALMORTALITYMARKERDAMAGECKD

식별자

Scopus EID
2-s2.0-85055077528
WoS UID
000447430800046